Daily non-political popular news in brief.

UCLA researchers discover biomarkers that predict lung cancer patient response to therapy

Researchers at UCLA's Jonsson Cancer Center have discovered biomarkers that predict which patients with advanced non-small cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex and the growth factor receptor blocker Tarceva.

Read more »

Keywords: ucla, researchers, discover, biomarkers, predict, lung, cancer, patient, response, therapy, researcher, biomarker

« Previous | Next »

Similar news on "UCLA researchers discover biomarkers that predict lung cancer patient response to therapy":

1. Breast cancer susceptibility gene predicts outcome and response to treatment in lung cancer
   09-25-2007 · EurekAlert!
   Researchers have found that the breast cancer susceptibility gene, BRCA1, plays a significant role in nonsmall cell lung cancer. They told the European Cancer Conference in Barcelona that not only can it be used to predict outcome for patients with NSCLC, but it may also prove to be a valuable tool in choosing the best therapy for them.
   Similar news · Read more »
   
2. Researchers discover new way to predict survival in older women with lung cancer
   11-01-2007 · EurekAlert!
   Researchers at UCLA's Jonsson Comprehensive Cancer Center have discovered a novel mechanism to predict survival in older women with early-stage lung cancer. The finding may have significant implications for new treatment approaches.
   Similar news · Read more »
   
3. Genes and biomarkers that allow doctors to choose the right therapy for the right patient
   04-17-2007 · EurekAlert!
   Genetic and epigenetic variations ensure that no two people are exactly alike, and the same holds true for any two cancers. Now, researchers have the tools and the knowledge to help predict how individuals will respond to cancer therapies, enabling them to create more effective therapies for individual cancers -- personalized medicine.
   Similar news · Read more »
   
4. Genomic tests improve prediction of breast cancer response to chemotherapy, hormonal therapy
   12-14-2006 · EurekAlert!
   Researchers at the University of Texas M. D. Anderson Cancer Center have developed two genomic tests to better predict how breast cancer patients will respond to chemotherapy or hormonal therapy.
   Similar news · Read more »
   
5. New biomarker predicts effectiveness of breast cancer drugs
   12-07-2006 · EurekAlert!
   University of Cincinnati researchers have identified a new way to predict when anti-estrogen drug therapies are inappropriate for patients with hormone-dependent breast cancer.Scientists say these findings could help physicians more accurately predict which tumors will respond to anti-estrogen therapy and improve long-term survival for breast cancer patients.
   Similar news · Read more »
   
6. UCLA researchers discover novel pathway that may promote immune system balance
   06-07-2007 · EurekAlert!
   Researchers at UCLA's Jonsson Cancer Center have discovered a novel anti-inflammatory cell signaling pathway that may serve as a vital Yin-Yang mechanism to maintain the delicate balance of immune response.
   Similar news · Read more »
   
7. Using nanotechnology, UCLA researchers discover cancer cells 'feel' much softer than normal cells
   12-02-2007 · EurekAlert!
   A multidisciplinary team of UCLA scientists were able to differentiate metastatic cancer cells from normal cells in patient samples using leading-edge nanotechnology that measures the softness of the cells.
   Similar news · Read more »
   
8. New biomarker test could predict outcome for bladder cancer patients
   02-01-2007 · EurekAlert!
   A set of molecular biomarkers might better predict the recurrence of bladder cancer than conventional prognostic features such as the stage or grade of the malignancy at the time it is discovered, UT Southwestern Medical Center researchers have found.
   Similar news · Read more »
   
9. New biomarker test could predict outcome for bladder cancer patients
   02-01-2007 · UT Southwestern Medical Center
   A set of molecular biomarkers might better predict the recurrence of bladder cancer than conventional prognostic features such as the stage or grade of the malignancy at the time it is discovered, UT Southwestern Medical Center researchers have found.
   Similar news · Read more »
   
10. Microarray provides 3 genomic guides to breast cancer treatment decisions
    09-06-2007 · EurekAlert!
    Three genomic tests separately predict the likelihood that a patient's breast cancer will reoccur after surgery without additional treatment, and the cancer's vulnerability to chemotherapy or hormone therapy, researchers at the University of Texas M. D. Anderson Cancer Center report at the first American Society of Clinical Oncology ASCO Breast Cancer Symposium, Sept. 7-8, in San Francisco.
    Similar news · Read more »